| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.94B | 4.55B | 3.93B | 4.80B | 4.69B | 3.36B |
| Gross Profit | 982.00M | 783.00M | 725.00M | 860.00M | 735.00M | 539.00M |
| EBITDA | 124.00M | 117.00M | 134.00M | 209.00M | 272.00M | 133.00M |
| Net Income | -79.00M | -290.00M | 4.00M | 92.00M | 150.00M | 43.00M |
Balance Sheet | ||||||
| Total Assets | 3.20B | 3.41B | 1.82B | 2.03B | 2.07B | 1.87B |
| Cash, Cash Equivalents and Short-Term Investments | 25.00M | 35.00M | 5.00M | 98.00M | 29.00M | 70.00M |
| Total Debt | 682.00M | 664.00M | 558.00M | 617.00M | 135.00M | 116.00M |
| Total Liabilities | 1.62B | 1.80B | 1.23B | 1.44B | 998.00M | 802.00M |
| Stockholders Equity | 1.58B | 1.61B | 594.00M | 587.00M | 1.07B | 1.07B |
Cash Flow | ||||||
| Free Cash Flow | -18.00M | -57.00M | 25.00M | 253.00M | 116.00M | -22.00M |
| Operating Cash Flow | 37.00M | -12.00M | 89.00M | 310.00M | 155.00M | 25.00M |
| Investing Cash Flow | -68.00M | -1.06B | -66.00M | -56.00M | -38.00M | -39.00M |
| Financing Cash Flow | 2.00M | 1.11B | -117.00M | -183.00M | -158.00M | 32.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $1.82B | 74.78 | 1.78% | 1.83% | -3.42% | -43.86% | |
66 Neutral | $1.78B | 18.77 | 7.40% | 0.61% | -5.34% | -48.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $4.69B | 41.26 | 3.81% | 1.40% | 5.46% | 2.31% | |
58 Neutral | $948.08M | 48.91 | 2.53% | 2.05% | -9.74% | -42.57% | |
52 Neutral | $425.76M | -10.57 | -6.66% | 2.60% | -7.55% | -130.67% | |
44 Neutral | $2.40B | -33.08 | -4.58% | ― | 53.85% | 77.68% |
On November 6, 2025, RXO reported its financial results for the third quarter of 2025, revealing a revenue increase to $1.4 billion from $1.0 billion in the previous year, despite a GAAP net loss of $14 million. The company experienced a tightening in the full-truckload market due to capacity exits, affecting its brokerage gross margin. RXO’s strategic decisions and cost initiatives are expected to yield over $30 million in savings, positioning the company for long-term growth despite current market challenges.